Takeda Pharmaceutical (TKPHF.PK) agrees to buy closely-held Swiss rival Nycomed for €9.6B...

|About: Takeda Pharmaceutical Co... (TKPHF)|By:, SA News Editor

Takeda Pharmaceutical (TKPHF.PK) agrees to buy closely-held Swiss rival Nycomed for €9.6B ($13.7B) in a move that will extend Takeda's reach into emerging markets. The price tag, which is slightly larger than had been expected, includes €3.6B of net debt.